Clinical Trial Update: PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA) [Phase 3]

View source ↗

Summary

The document notes the completion of a Phase 3 open-label trial evaluating MRA for rheumatoid arthritis, sponsored by Chugai Pharmaceutical.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MRA (MRA)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED